Stock Ratings / Health Care / APT / options

MYO (37) COCH (42) NTRB (40) CNXU (56) ⌘ Pro Terminal →

Alpha Pro Tech Ltd. (APT) Options Positioning, Max Pain & Unusual Sweeps

$5.55 +1.28% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $5.55

Alpha Pro Tech Ltd. (APT) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $56.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $5.55 (+0.04%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 2.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for APT)Realized 20D OHLCV Swing Band: ±9.8%

Deterministic 5-Pillar Attribution (58/100 Composite)

🔍 WHY APT SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (28% of score)

Altman Z-Score 5.59 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+13/20 pts (22% of score)

SEC Form 4 / 13F Thermometer: 65% Net Buy • Cannibal Buyback (-1.52% YoY Shares)

▼ #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$5.84-5% Next Q

Q2 (-2Q)

Grade C+$5.55+0.2% Next Q

Q3 (-1Q)

Grade C$5.56-0.2% Next Q

Current

Grade D+$5.55+0% Hist 90D α

Trajectory: B- (66) → D+ (58)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the APT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 58/100 (D+) score, APT faces multiple-compression risk if 16.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 35.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($5.39) or 200D SMA ($5.19) invalidates the momentum regime and cuts Target Base ($5.55) toward Bear Floor ($4.33).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $APT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “APT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 58%NO 42%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±9.8%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (APT)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for APT.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring APT)

✓Walkthrough of APT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

APT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +20.65%▲ ASCENDING CHANNEL

2026-10-30O $5.54H $5.55L $5.31C $5.55VOL 29.2K

RES: $6.47SUP: $5.06SMA50: $5.39SMA200: $5.19

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

APT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 APT Butterfly Map → + Track APT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.8%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on APT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for APT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for APT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (APT)

Health Care Rank #236 of 1016 ⚔️ MYO vs APT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (APT vs. MYO, COCH, NTRB, CNXU)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Alpha Pro Tech Ltd. (APT) ranks #236 by composite RQD confidence (58/100, grade D+) and #731 by equity capitalization ($56.6M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently leads its immediate peer cohort in composite quantitative strength at 58/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
APT ACTIVE Alpha Pro Tech Ltd.	D+	58/100	16.2x	38.1%	6.7%	+1.28%	$56.6M	Benchmark Subject
MYO Myomo Inc.	D-	37/100	—	65.7%	-35.0%	+3.18%	$51.5M	/myo-vs-apt →
COCH Envoy Medical Inc. (Class A)	D-	42/100	—	-30.0%	-35.0%	-2.40%	$50.3M	/coch-vs-apt →
NTRB Nutriband Inc.	D-	40/100	—	27.8%	-35.0%	+3.75%	$80.7M	/ntrb-vs-apt →
CNXU Conexeu Sciences Inc.	D+	56/100	—	—	—	-1.74%	$85.8M	/cnxu-vs-apt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000884269

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alpha Pro Tech Ltd. (APT) reported GAAP revenue of $59.1M (+2.3% vs. FY2024 revenue of $57.8M ) , GAAP net income of $3.5M, operating cash flow of $2.4M, and free cash flow of $1.7M (-8.5% YoY). On the balance sheet, APT closed FY2025 with $74.1M in total assets against $0 in total debt (Altman Z-Score: 5.59, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$59.1M	$3.5M	$2.4M	$1.7M	$74.1M	—
FY2024 (FY)	2024-12-31	$57.8M	$3.9M	$5.7M	$1.9M	$73.7M	—
FY2023 (FY)	2023-12-31	$0	$4.2M	$8.5M	$8.5M	—	—

3. APT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Alpha Pro Tech Ltd. (NYSE: APT) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $5.55 (+1.28% 1D, market cap $56.6M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, APT ranks #236 in composite RQD confidence.

How does APT compare to MYO and COCH in the Health Care sector?

Within the Health Care sector (Industrial Specialties), APT carries a Roarable D+ (58/100 RQD), trailing P/E of 16.2x, gross margin of 38.1%, and ROIC of 6.7%. By comparison, MYO (Myomo Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $51.5M) and COCH (Envoy Medical Inc. (Class A)) posts a D- grade (42/100 RQD, P/E N/A, ROIC -35.0%, cap $50.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for APT?

Per APT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884269), Alpha Pro Tech Ltd. generated $59.1M in revenue (+2.3% YoY), $3.5M in net income, and $1.7M in free cash flow against $74.1M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is APT trading relative to its 50-day, 200-day, and 52-week technical levels?

APT last traded at $5.55 (+1.28% on volume of 8,085 shares), positioning the stock +2.97% above its 50-day simple moving average ($5.39) and +6.94% above its 200-day simple moving average ($5.19). Across its 52-week range of $4.34 to $7.50, APT sits at the 38.3% percentile with a 14-day RSI of 46.6 (NEUTRAL RANGE) and an implied next-earnings move of ±9.8% ($5.01 to $6.09).

APT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is APT's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for APT.

Direct Sub-Reports: APT RQD Cockpit APT 12M Forecast APT Earnings & Move APT Dividends & DRIP APT Insiders & 13F APT Whale Options APT Profit Sankey APT News & Why